296 related articles for article (PubMed ID: 14972004)
1. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
2. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
5. HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.
Sikorska K; Bielawski KP; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Romanowski T
Int J Mol Med; 2005 Dec; 16(6):1151-6. PubMed ID: 16273299
[TBL] [Abstract][Full Text] [Related]
6. C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease.
Ropero Gradilla P; Villegas Martínez A; Fernández Arquero M; García-Agúndez JA; González Fernández FA; Benítez Rodríguez J; Díaz-Rubio M; de la Concha EG; Ladero Quesada JM
Rev Esp Enferm Dig; 2001 Mar; 93(3):156-63. PubMed ID: 11469076
[TBL] [Abstract][Full Text] [Related]
7. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
8. The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.
Carneiro MV; Souza FF; Teixeira AC; Figueiredo JF; Villanova MG; Secaf M; Passos AD; Ramalho LN; Carneiro FP; Zucoloto S; Candolo Martinelli AL
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1204-10. PubMed ID: 20555268
[TBL] [Abstract][Full Text] [Related]
9. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
[TBL] [Abstract][Full Text] [Related]
10. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S
J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716
[TBL] [Abstract][Full Text] [Related]
11. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
12. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
[TBL] [Abstract][Full Text] [Related]
13. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
14. HFE haemochromatosis gene mutations in liver transplant patients.
Halme L; Heliö T; Mäkinen J; Höckerstedt K; Färkkilä M; Piippo K; Krusius T; Kontula K
Scand J Gastroenterol; 2001 Aug; 36(8):881-5. PubMed ID: 11495086
[TBL] [Abstract][Full Text] [Related]
15. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
[TBL] [Abstract][Full Text] [Related]
16. HFE gene mutations in patients with alcoholic liver disease. A prospective study from northwestern Poland.
Raszeja-Wyszomirska J; Kurzawski G; Zawada I; Suchy J; Lubinski J; Milkiewicz P
Pol Arch Med Wewn; 2010 Apr; 120(4):127-31. PubMed ID: 20424537
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
[TBL] [Abstract][Full Text] [Related]
18. [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].
Ropero P; Briceño O; López-Alonso G; Agúndez JA; González Fernández FA; García-Hoz F; Villegas Martínez A; Díaz-Rubio M; Ladero JM
Rev Esp Enferm Dig; 2007 Jul; 99(7):376-81. PubMed ID: 17973580
[TBL] [Abstract][Full Text] [Related]
19. Histological evaluation of iron in liver biopsies: relationship to HFE mutations.
Brunt EM; Olynyk JK; Britton RS; Janney CG; Di Bisceglie AM; Bacon BR
Am J Gastroenterol; 2000 Jul; 95(7):1788-93. PubMed ID: 10925986
[TBL] [Abstract][Full Text] [Related]
20. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]